Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis - Summary - MDSpire
Advertisement
Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis
To evaluate the incidence of specific gastrointestinal symptoms (e.g., diarrhea, nausea) and liver enzyme alterations in hospitalized COVID-19 patients and analyze their association with disease severity and clinical outcomes.
Key Findings:
A significant incidence of gastrointestinal symptoms was observed in hospitalized COVID-19 patients (p < 0.05).
Alterations in liver enzymes were correlated with disease severity (p < 0.01).
Gastrointestinal symptoms may serve as prognostic indicators for ICU admission and mortality.
Interpretation:
The presence of gastrointestinal symptoms and liver enzyme alterations in COVID-19 patients may indicate a higher risk of severe disease and poor clinical outcomes, such as increased likelihood of ICU admission and mortality.
Limitations:
The study was conducted in a single hospital, which may limit generalizability to other settings.
Exclusion of patients with pre-existing gastrointestinal or liver conditions may affect the findings, potentially underestimating the true incidence of symptoms.
Conclusion:
Gastrointestinal symptoms and liver enzyme levels are important factors in assessing the severity and prognosis of COVID-19 in hospitalized patients.
by Thiago Henrique Fernandes de Carvalho, Fabyan Beltrão Esberard, Maryana Cavalcanti Holanda, Matheus Venâncio de Paiva, Daniele Carvalhal de Almeida Beltrão, Giulia Carvalhal, José Felipe Lacerda Fernandes, Carlos Alexandre Antunes de Brito
